The five hundred species of cone snails produce small, conformationally constrained peptides in their venoms which generally target receptors and ion channels in the nervous system. The many tens-of- thousands of different Conus peptides are generated by only a few superfamilies, and are organized within each venom into groups of peptides which act synergistically for a common physiological objective. One general goal of this program is the continuing identification and characterization of Conus peptides which target novel receptor and ion channel subtypes. However, another major goal is to understand the underlying principles of molecular recognition and drug development that the cone snails have evolved. The program is organized into a venom resource core, a peptide chemistry core and an electrophysiological core. These cores also directly support """"""""discovery cores"""""""" that are exploratory and/or collaborative on Conus peptides which are not directly supported as projects. Three major projects comprise the program. The goal of the first project is to understand the underlying design of Conus peptides that allow them to discriminate between closely related target receptors. The standard features of Conus peptides which confer target selectively will be identified. The second project focuses on a few fish-hunting Conus venoms; the goal is to understand in mechanistic detail how efficient prey capture is achieved by elucidating the role of each individual Conus peptide, and evaluating the synergy between groups of peptides. Finally, the third project investigates the genetic basis of Conus peptide hypervariability, and in addition characterize the enzymatic basis of an unusual post-translational modification, the gamma-carboxylation of glutamate residues.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM048677-10
Application #
6490055
Study Section
Special Emphasis Panel (ZRG3-SSS-2 (02))
Program Officer
Cole, Alison E
Project Start
1993-01-01
Project End
2002-12-31
Budget Start
2002-01-01
Budget End
2002-12-31
Support Year
10
Fiscal Year
2002
Total Cost
$1,034,205
Indirect Cost
Name
University of Utah
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Yan, Yijin; Peng, Can; Arvin, Matthew C et al. (2018) Nicotinic Cholinergic Receptors in VTA Glutamate Neurons Modulate Excitatory Transmission. Cell Rep 23:2236-2244
Hone, Arik J; McIntosh, J Michael (2018) Nicotinic acetylcholine receptors in neuropathic and inflammatory pain. FEBS Lett 592:1045-1062
Hone, Arik J; Talley, Todd T; Bobango, Janet et al. (2018) Molecular determinants of ?-conotoxin potency for inhibition of human and rat ?6?4 nicotinic acetylcholine receptors. J Biol Chem 293:17838-17852
Banala, Sambashiva; Arvin, Matthew C; Bannon, Nicholas M et al. (2018) Photoactivatable drugs for nicotinic optopharmacology. Nat Methods 15:347-350
Hone, Arik J; Servent, Denis; McIntosh, J Michael (2018) ?9-containing nicotinic acetylcholine receptors and the modulation of pain. Br J Pharmacol 175:1915-1927
Espino, Samuel S; Robinson, Samuel D; Safavi-Hemami, Helena et al. (2018) Conopeptides promote itch through human itch receptor hMgprX1. Toxicon 154:28-34
Richter, Katrin; Sagawe, Sabrina; Hecker, Andreas et al. (2018) C-Reactive Protein Stimulates Nicotinic Acetylcholine Receptors to Control ATP-Mediated Monocytic Inflammasome Activation. Front Immunol 9:1604
Hiller, Sebastian Daniel; Heldmann, Sarah; Richter, Katrin et al. (2018) ?-Nicotinamide Adenine Dinucleotide (?-NAD) Inhibits ATP-Dependent IL-1? Release from Human Monocytic Cells. Int J Mol Sci 19:
Peng, Can; Yan, Yijin; Kim, Veronica J et al. (2018) Gene editing vectors for studying nicotinic acetylcholine receptors in cholinergic transmission. Eur J Neurosci :
Chen, De-Jie; Gao, Fen-Fei; Ma, Xiao-Kuang et al. (2018) Pharmacological and functional comparisons of ?6/?3?2?3-nAChRs and ?4?2-nAChRs heterologously expressed in the human epithelial SH-EP1 cell line. Acta Pharmacol Sin 39:1571-1581

Showing the most recent 10 out of 277 publications